跳至主要内容
临床试验/NCT04907097
NCT04907097已完成不适用

Effect of Monomeric and Oligomeric Flavanols on Exercise Blood Pressure and Vascular Function in Healthy Volunteers

Maastricht University Medical Center2 个研究点 分布在 1 个国家目标入组 40 人开始时间: 2022年4月5日最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
入组人数
40
试验地点
2
主要终点
Change in systolic blood pressure from before to peak value during the submaximal exercise test

研究概览

简要总结

The purpose of this study is to establish an effect of monomeric and oligomeric flavanols supplementation on exercise blood pressure and vascular function in healthy volunteers.

详细描述

Exaggerated exercise blood pressure (BP) response in healthy subjects is recognized as a risk factor of hypertension and cardiovascular events. Pathogenetically exaggerated BP response is attributed to compromised vascular(endothelial) functions as well as oxidative stress and inflammation. Monomeric and oligomeric flavanols (MOF) are dietary components with well-characterized beneficial effects on the redox homeostasis, endothelial function and microvascular health.

The objectives of the study will be to evaluate the effects of MOF in comparison to placebo on exercise blood pressure, endothelial function, inflammatory and redox status in healthy prehypertensive volunteers. In addition, the study will aim to assess the impact of MOF supplementation on the exercise-induced renin-angiotensin-aldosterone system (RAAS) activation and extracellular matrix remodelling.

After being informed about the study and potential risks all volunteers signing informed consent form will undergo screening to determine eligibility for the study. Eligible subjects will be randomized in the double-blind manner to monomeric and oligomeric flavanols /placebo or placebo/monomeric and oligomeric flavanols sequence (cross-over design) in a 1:1 ratio. Monomeric and oligomeric flavanols are derived from grape seeds extract and will be administered in a dose 200 mg per day.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Crossover
主要目的
Prevention
盲法
Triple (Participant, Investigator, Outcomes Assessor)

入排标准

年龄范围
35 Years 至 65 Years(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Healthy men and women with normal to high-normal resting BP (SBP 120 - 139 mm Hg and DBP 80 - 89 mm Hg).
  • Age 35 - 65 years
  • BMI 20 - 32 kg/m^2
  • Hypertensive response to maximal exercise test defined as SBP ≥ 200 mm Hg (men) and ≥ 180 mm Hg (women).

排除标准

  • Active engagement in the weight loss programs, also including slimming diets.
  • Active smoking or abstinence from smoking for less than one year.
  • Use of medications that reduce BP and/or can potentially influence other study outcomes (ACE-inhibitors, angiotensin receptor blockers, diuretics, painkillers, etc).
  • Intake of polyphenol-containing supplements for two month before and during the whole course of the study.
  • History of diabetes, cardiovascular, respiratory, renal, gastrointestinal, hepatic or other diseases and conditions, which potentially can compromise participation in this study.
  • Intense sporting (>10 h/week) and/or participation in the competition at the professional level.
  • Pregnancy or breastfeeding.
  • Participation in a clinical trial within 4 weeks prior to inclusion into this study.
  • Vaccination against Covid-19 within two months before the screening/randomization visit or expected vaccination against Covid-19 during the study

结局指标

主要结局

Change in systolic blood pressure from before to peak value during the submaximal exercise test

时间窗: Day 28±3, Day 84±3

Excessive increase in systolic blood pressure during exercise is a well-characterized risk-factor of cardiovascular disease and is related to signs of sub clinical endothelial dysfunction.

Change in mean blood pressure from before to peak value during the submaximal exercise test

时间窗: Day 28±3, Day 84±3

Increase in mean blood pressure during exercise is related to signs of endothelial dysfunction.

次要结局

  • Carotid-femoral pulse wave velocity(Day 28±3, Day 84±3)
  • Biomarkers of RAAS activation(Day 28±3, Day 84±3)
  • Biomarkers of inflammation(Day 28±3, Day 84±3)
  • Biomarkers of oxidative stress(Day 28±3, Day 84±3)
  • Biomarkers of endothelial function(Day 28±3, Day 84±3)
  • Biomarkers of vascular remodelling(Day 28±3, Day 84±3)
  • Other hemodynamic parameters(Day 28±3, Day 84±3)

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Khrystyna Semen

Professor assistant

Maastricht University Medical Center

研究点 (2)

Loading locations...

相似试验

Effect of MOF on Exercise Blood Pressure | 临床试验